ArticleACS nano medicine2026

Intracellular Nanopharmacology of Trastuzumab Deruxtecan Reveals Lysosome-Centered Organelle Vulnerabilities in HER2-Positive Breast Cancer Cells.

Erica Tagliatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.